应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01548 金斯瑞生物-一千
未开盘 10-21 16:08:20
34.320
+0.900
+2.69%
最高
36.660
最低
32.880
成交量
3,614万
今开
34.180
昨收
33.420
日振幅
11.31%
总市值
783.87亿
流通市值
783.87亿
总股本
22.84亿
成交额
12.56亿
换手率
1.58%
流通股本
22.84亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
FMR LLC增持金斯瑞生物(01548)约474.32万股 每股作价32.7813港元
智通财经 · 10-21 19:04
FMR LLC增持金斯瑞生物(01548)约474.32万股 每股作价32.7813港元
港股异动 | 金斯瑞生物科技(01548)早盘涨近9% CARVYKTI三季度销售额7.1亿美元 环比持续放量
智通财经 · 10-21 09:48
港股异动 | 金斯瑞生物科技(01548)早盘涨近9% CARVYKTI三季度销售额7.1亿美元 环比持续放量
异动解读｜金斯瑞生物科技盘中上涨5.92%，机构连续增持支撑资金情绪
行情直击 · 10-21 09:30
异动解读｜金斯瑞生物科技盘中上涨5.92%，机构连续增持支撑资金情绪
Pandanus Partners L.P.增持金斯瑞生物(01548)1055.2万股 每股作价约35.98港元
智通财经网 · 10-20 19:02
Pandanus Partners L.P.增持金斯瑞生物(01548)1055.2万股 每股作价约35.98港元
异动解读｜金斯瑞生物科技盘中上涨3.3%，FMR LLC连续增持支撑资金情绪
行情直击 · 10-20 09:54
异动解读｜金斯瑞生物科技盘中上涨3.3%，FMR LLC连续增持支撑资金情绪
创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%
老虎资讯综合 · 10-16
创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%
生物医药板块走强 康诺亚-B（02162）涨9.00%、金斯瑞生物科技（01548）涨7.53%
金吾财讯 · 10-16
生物医药板块走强 康诺亚-B（02162）涨9.00%、金斯瑞生物科技（01548）涨7.53%
港股异动 | 金斯瑞生物(01548.HK)涨超8% 阿斯利康加入“AI+制药”热潮 AI制药有望成AI应用主要方向
智通财经 · 10-16
港股异动 | 金斯瑞生物(01548.HK)涨超8% 阿斯利康加入“AI+制药”热潮 AI制药有望成AI应用主要方向
异动解读｜金斯瑞生物科技盘中上涨6.84%，FMR LLC再度增持提振资金情绪
行情直击 · 10-16
异动解读｜金斯瑞生物科技盘中上涨6.84%，FMR LLC再度增持提振资金情绪
FMR LLC增持金斯瑞生物科技(01548)1036.99万股 每股作价约42.06港元
智通财经网 · 10-15
FMR LLC增持金斯瑞生物科技(01548)1036.99万股 每股作价约42.06港元
异动解读｜金斯瑞生物科技盘中下跌4.25%，CARVYKTI销售披露后资金博弈延续
行情直击 · 10-15
异动解读｜金斯瑞生物科技盘中下跌4.25%，CARVYKTI销售披露后资金博弈延续
异动解读｜金斯瑞生物科技盘中上涨3.21%，CARVYKTI三季度销售额约7.1亿美元
行情直击 · 10-14
异动解读｜金斯瑞生物科技盘中上涨3.21%，CARVYKTI三季度销售额约7.1亿美元
金斯瑞生物科技(01548.HK)：CARVYKTI®于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元
智通财经 · 10-13
金斯瑞生物科技(01548.HK)：CARVYKTI®于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元
金斯瑞生物科技：传奇生物核心产品第三季度贸易销售净额约7.1亿美元
南方财经网 · 10-13
金斯瑞生物科技：传奇生物核心产品第三季度贸易销售净额约7.1亿美元
金斯瑞生物科技（01548）：CARVYKTI®截至2026年9月季度贸易销售净额约7.1亿美元
公告速递 · 10-13
金斯瑞生物科技（01548）：CARVYKTI®截至2026年9月季度贸易销售净额约7.1亿美元
【券商聚焦】东北证券予金斯瑞生物科技（01548）买入评级 指AI赋能主业
金吾财讯 · 10-13
【券商聚焦】东北证券予金斯瑞生物科技（01548）买入评级 指AI赋能主业
港股异动 | 医药股普遍走低，CRO概念跌幅居前 金斯瑞生物科技(01548.HK)一度跌超18%
智通财经 · 10-13
港股异动 | 医药股普遍走低，CRO概念跌幅居前 金斯瑞生物科技(01548.HK)一度跌超18%
港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%
老虎资讯综合 · 10-13
港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%
异动解读｜金斯瑞生物科技盘中下跌7.26%，AIDD概念板块整体回调承压
行情直击 · 10-13
异动解读｜金斯瑞生物科技盘中下跌7.26%，AIDD概念板块整体回调承压
金斯瑞联手英伟达举办生命科学初创企业创投大赛
智通财经 · 10-12
金斯瑞联手英伟达举办生命科学初创企业创投大赛
加载更多
公司概况
公司名称：
金斯瑞生物-一千
所属市场：
SEHK
上市日期：
--
主营业务：
金斯瑞生物科技股份有限公司是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司。该公司通过五个分部开展业务。生命科学服务及产品分部提供全面的研究服务及产品。生物制剂开发服务分部以一个综合平台提供全面服务，旨在帮助生物制药及生物技术公司加快治疗性抗体及基因、细胞疗法产品的开发。工业合成生物产品分部通过使用基因工程建构非病源微生物株，提供工业酶开发和生产。细胞疗法分部发现和开发用于治疗液体及固体肿瘤的CAR-T疗法。经营管理分部主要为其他分部提供共享服务。该公司主要在中国国内和海外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"金斯瑞生物-一千","latestPrice":34.32,"timestamp":1792570100004,"preClose":33.42,"halted":0,"volume":36140984,"delay":0,"changeRate":0.026929982046678593,"floatShares":2284000000,"shares":2284000000,"eps":-0.2458,"marketStatus":"未开盘","change":0.9,"latestTime":"10-21 16:08:20","open":34.18,"high":36.66,"low":32.88,"amount":1256106358,"amplitude":0.113106,"askPrice":34.32,"askSize":8000,"bidPrice":34.3,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":-2.288748,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792632600000},"marketStatusCode":0,"adr":0,"listingDate":1451404800000,"exchange":"SEHK","adjPreClose":33.42,"openAndCloseTimeList":[[1792546200000,1792555200000],[1792558800000,1792569600000]],"volumeRatio":0.6295967235813087,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548","defaultTab":"news","newsList":[{"id":"2677284673","title":"FMR LLC增持金斯瑞生物(01548)约474.32万股 每股作价32.7813港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677284673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677284673?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:04","pubTimestamp":1792580683,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，10月15日，FMR LLC增持金斯瑞生物(01548)474.3157万股，每股作价32.7813港元，总金额约为1.55亿港元。增持后最新持股数目约为1.87亿股，最新持股比例为8.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","HK0000306685.HKD","EWH","HK0000306701.USD","BK1583","HK0000320223.HKD","BK1576","01548","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677645522","title":"港股异动 | 金斯瑞生物科技(01548)早盘涨近9% CARVYKTI三季度销售额7.1亿美元 环比持续放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2677645522","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677645522?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:48","pubTimestamp":1792547307,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技早盘涨近9%。截至发稿，涨7.18%，报35.82港元，成交额3.86亿港元。消息面上，金斯瑞生物科技近日公告，传奇生物披露CARVYKTI在2026年三季度的贸易销售净额约为7.1亿美元。结合上半年12.54亿美元的收入，Carvykti前三季度累计销售约19.64亿美元，同比增长47.4%。从季度走势看，该产品Q1销售5.97亿美元，Q2达6.57亿美元，Q3进一步攀升至7.1亿美元，环比持续放量。值得注意的是，9月16日，金斯瑞生物宣布与礼来的AIDD协作平台Lilly TuneLab达成合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","KCAI","HK0000306701.USD","BK4585","BK1583","BK4588","HK0000320264.USD","HK0000306685.HKD","HK0000320223.HKD","01548","BK1576","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199588396","title":"异动解读｜金斯瑞生物科技盘中上涨5.92%，机构连续增持支撑资金情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1199588396","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199588396?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:30","pubTimestamp":1792546253,"startTime":"0","endTime":"0","summary":"10月21日，金斯瑞生物科技盘中上涨5.92%，报35.22港元，成交额3169.39万港元。消息面上，近期公司获多家机构连续加仓，其中Pandanus Partners L.P.于10月13日增持1055.2万股，每股作价35.9824港元，涉资约3.80亿港元；更早前FMR LLC于10月12日增持1036.99万股，涉资约4.36亿港元，且此前已于9月24日、10月2日连续增持。此外，公司联营公司传奇生物核心产品CARVYKTI截至9月30日止季度贸易销售净额约7.1亿美元，进一步强化市场对其细胞疗法与生命科学服务业务成长性的关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"金斯瑞生物科技异动上涨，机构连续增持引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676660183","title":"Pandanus Partners L.P.增持金斯瑞生物(01548)1055.2万股 每股作价约35.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676660183","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676660183?lang=zh_cn&edition=full","pubTime":"2026-10-20 19:02","pubTimestamp":1792494162,"startTime":"0","endTime":"0","summary":"10月13日，Pandanus Partners L.P.增持金斯瑞生物(01548)1055.2万股，每股作价35.9824港元，总金额约为3.80亿港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20261020/20261020190307_95082.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261020/20261020190307_95082.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","EWH","HK0000306701.USD","01548","HK0000306685.HKD","HK0000320223.HKD","BK1576","BK1583","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140825332","title":"异动解读｜金斯瑞生物科技盘中上涨3.3%，FMR LLC连续增持支撑资金情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1140825332","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140825332?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:54","pubTimestamp":1792461297,"startTime":"0","endTime":"0","summary":"10月20日，金斯瑞生物科技盘中上涨3.3%，报34.4港元，成交额3.11亿港元。消息面上，FMR LLC于10月12日增持公司1036.99万股，每股作价42.0590港元，涉资约4.36亿港元，增持后持股升至约1.66亿股，持股比例达7.26%。此前FMR LLC已于9月24日、10月2日连续加仓；同时，公司联营公司传奇生物核心产品CARVYKTI®截至9月30日止季度贸易销售净额约7.1亿美元，强化市场对其细胞疗法与生命科学服务业务成长性的关注。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"金斯瑞生物科技上涨，FMR LLC连续增持提振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109072607","title":"创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109072607","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109072607?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:51","pubTimestamp":1792115499,"startTime":"0","endTime":"0","summary":"港股创新药概念股续升，康诺亚涨超12%，云顶新耀涨超11%，金斯瑞生物涨近8%，百济神州涨超6%，再鼎医药涨近5%，药明合联、药明生物涨超4%，药明康德涨近4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","02359","02162","01548","02268","02269","06160","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675542315","title":"生物医药板块走强 康诺亚-B（02162）涨9.00%、金斯瑞生物科技（01548）涨7.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675542315","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675542315?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:37","pubTimestamp":1792114658,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走强，康诺亚-B 涨9.00%，金斯瑞生物科技涨7.53%，百济神州涨5.38%，科伦博泰生物涨5.25%，再鼎医药涨4.46%，君实生物涨3.71%，泰格医药涨3.65%，复宏汉霖涨2.99%。中信建投证券表示，2026 ESMO LBA中国研究入选创新高，恒瑞医药、康方生物、艾力斯等企业的管线迎来新进展。医药商业板块跑赢申万医药及大盘，药店关注三季度前瞻及集采进药店，流通关注回款及三季度前瞻。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993835","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688","BK1587","LU1251922891.USD","01548","HK0000320264.USD","HK0000306701.USD","LU0196878994.USD","LU1770034418.SGD","XBI","KURE","LU0307460666.USD","02162","02696","399441","BK4588","HK0000165453.HKD","BK1500","LU2488822045.USD","HK0000306685.HKD","161726","LU2328871848.SGD","BK1515","03347","BK1574","06990","LU0228659784.USD","LU0828237510.HKD","BK4585","BK1583","01877","LU1969619763.USD","HK0000320223.HKD","BK1161","BK1588","06160","BK4581","LU1303224171.USD","LU1719994722.HKD","LU0588546209.SGD","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554441","title":"港股异动 | 金斯瑞生物(01548.HK)涨超8% 阿斯利康加入“AI+制药”热潮 AI制药有望成AI应用主要方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675554441?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:35","pubTimestamp":1792114541,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01548","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD","BK1583","BK1141","BK1574","HK0000306685.HKD","01477","BK1576","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179554932","title":"异动解读｜金斯瑞生物科技盘中上涨6.84%，FMR LLC再度增持提振资金情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1179554932","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179554932?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:30","pubTimestamp":1792114254,"startTime":"0","endTime":"0","summary":"10月16日，金斯瑞生物科技盘中上涨6.84%，报33.76港元，成交额4260.15万港元。消息面上，FMR LLC于10月12日增持公司1036.99万股，每股作价42.0590港元，涉资约4.36亿港元。此前FMR LLC已于9月24日、10月2日连续增持，公司持股比例曾升至6.01%。在CARVYKTI截至9月季度贸易销售净额约7.1亿美元披露后，机构持续加仓，强化了市场对公司细胞疗法与生命科学服务业务中长期成长性的关注。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金斯瑞生物科技大涨，FMR再度增持引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675811765","title":"FMR LLC增持金斯瑞生物科技(01548)1036.99万股 每股作价约42.06港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675811765","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675811765?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:13","pubTimestamp":1792062829,"startTime":"0","endTime":"0","summary":"10月12日，FMR LLC增持金斯瑞生物科技(01548)1036.99万股，每股作价42.0590港元，总金额约为4.36亿港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20261015/20261015191429_81038.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261015/20261015191429_81038.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1141","HK0000320264.USD","BK1576","HK0000320223.HKD","BK1583","EWH","HK0000306685.HKD","01548","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170086366","title":"异动解读｜金斯瑞生物科技盘中下跌4.25%，CARVYKTI销售披露后资金博弈延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1170086366","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170086366?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:32","pubTimestamp":1792027950,"startTime":"0","endTime":"0","summary":"10月15日，金斯瑞生物科技盘中下跌4.25%，报34.22港元，成交额1.25亿港元。消息面上，公司此前披露联营公司传奇生物核心产品CARVYKTI截至9月30日止季度贸易销售净额约7.1亿美元，但相关数据基于合作方Janssen提供，传奇生物与公司均未独立核实。金斯瑞生物科技股份有限公司是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司。细胞疗法分部发现和开发用于治疗液体及固体肿瘤的CAR-T疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"金斯瑞生物科技下跌，CARVYKTI销售博弈延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114054661","title":"异动解读｜金斯瑞生物科技盘中上涨3.21%，CARVYKTI三季度销售额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114054661","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114054661?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:39","pubTimestamp":1791949143,"startTime":"0","endTime":"0","summary":"10月14日，金斯瑞生物科技盘中上涨3.21%，报36.7港元，成交额6.82亿港元。消息面上，公司最新披露联营公司传奇生物核心产品CARVYKTI截至9月30日止季度贸易销售净额约7.1亿美元，构成股价异动的直接催化。公告显示，该销售数据由合作方Janssen提供，传奇生物与金斯瑞均未独立核实。此前机构亦上调公司评级，认为CARVYKTI商业化放量叠加AI药物研发带动主业需求增长，有助强化市场对公司成长性的预期。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金斯瑞生物科技大涨，CARVYKTI销售超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675354406","title":"金斯瑞生物科技(01548.HK)：CARVYKTI®于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675354406","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675354406?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:37","pubTimestamp":1791895062,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","01548","HK0000306701.USD","BK1583","BK1576","HK0000320264.USD","HK0000306685.HKD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675354717","title":"金斯瑞生物科技：传奇生物核心产品第三季度贸易销售净额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675354717","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675354717?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:33","pubTimestamp":1791894780,"startTime":"0","endTime":"0","summary":"南财智讯10月13日电，金斯瑞生物科技（01548.HK）发布自愿公告，公司联营公司传奇生物已向美国证券交易委员会提交相关表格，宣布根据传奇与杨森订立的合作及许可协议，核心产品西达基奥仑赛于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元。贸易销售净额乃基于杨森向传奇提供的资料，传奇与公司均未独立核实该销售数字的准确性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610133894345938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610133894345938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01548","BK4505","BK1576","MEMS","BK1141","BK4139","CANC","BK4588","BK4585","HK0000306685.HKD","HK0000320223.HKD","LEGN","BK1583","HK0000306701.USD","HK0000320264.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138732682","title":"金斯瑞生物科技（01548）：CARVYKTI®截至2026年9月季度贸易销售净额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138732682","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138732682?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:31","pubTimestamp":1791894674,"startTime":"0","endTime":"0","summary":"2026年10月13日，金斯瑞生物科技股份有限公司（01548）发布自愿性公告称，其联营公司传奇生物科技股份有限公司已于同日向美国证券交易委员会提交6-K表格，并披露CARVYKTI®在截至2026年9月30日止季度录得约7.1亿美元的贸易销售净额。该销售数据基于合作伙伴Janssen Biotech, Inc.提供的资料，传奇生物和金斯瑞均未独立核实相关数字的准确性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675733333","title":"【券商聚焦】东北证券予金斯瑞生物科技（01548）买入评级 指AI赋能主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2675733333","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675733333?lang=zh_cn&edition=full","pubTime":"2026-10-13 14:06","pubTimestamp":1791871598,"startTime":"0","endTime":"0","summary":"生命科学事业群中Gene-to-Protein贡献约66%收入，药企及生物科技客户收入占比约82%；AIDD服务收入约4000万美元，同比增长超105%。百斯杰将AI与高通量实验用于工业酶和功能蛋白研发，推动AI能力向产品端兑现。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993536","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","QTOC","01548","000686","AIPO","CHAT","ARTY","VTHR","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675538230","title":"港股异动 | 医药股普遍走低，CRO概念跌幅居前 金斯瑞生物科技(01548.HK)一度跌超18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675538230","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675538230?lang=zh_cn&edition=full","pubTime":"2026-10-13 10:59","pubTimestamp":1791860394,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1583","HK0000320223.HKD","BK1574","BK1515","09939","01548","BK1161","BK1576","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157830362","title":"港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157830362","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157830362?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:38","pubTimestamp":1791855517,"startTime":"0","endTime":"0","summary":"10月13日，港股创新药概念股集体走低，$华昊中天医药-B(02563)$跌超11%，$金斯瑞生物科技(01548)$跌超10%，$药明合联(02268)$、$晶泰控股(02228)$跌超4%，$药明生物(02269)$、$歌礼制药-B(01672)$跌超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274308.USD","LU0051755006.USD","BK1610","LU0634319403.HKD","HK0000306701.USD","LU0029874061.USD","HK0000306685.HKD","LU0516422952.EUR","BK1141","LU1794554557.SGD","02268","LU0708995583.HKD","BK4588","01548","LU0348827113.USD","LU0359202008.SGD","LU0417516738.SGD","LU0463099449.HKD","LU0708995153.HKD","LU0327786744.USD","BK1576","LU2778985437.USD","KCAI","LU0128522744.USD","IE00B0JY6N72.USD","LU0823426480.USD","LU0516422440.USD","LU0540923850.HKD","LU0307460666.USD","LU1720050803.USD","HK0000320264.USD","02269","SG9999002562.SGD","BK4585","LU0359201612.USD","LU2039709279.SGD","LU0348825331.USD","LU0828237510.HKD","LU0516423091.SGD","IBBQ","VXUS","LU2476274720.SGD","LU0516423174.USD","LU0417516902.SGD","01477","LU0320764599.SGD","LU2488822045.USD","BK1161","HK0000320223.HKD","LU0244354667.USD","02228","LU0029874905.USD","LU0856984785.SGD","LU1880383366.USD","09939","LU0572944931.SGD","LU0228659784.USD","LU3063872942.SGD","LU1831875114.USD","BK1515","BK1617","BK1583","LU0456827905.SGD","SG9999002463.SGD","SG9999014674.SGD","LU0039217434.USD","LU0456846285.SGD","LU0588546209.SGD","LU0320764243.SGD","LU0516422366.SGD","LU1688375341.USD","LU0979878070.USD","LU0819121731.USD","02563","LU1242518857.USD","MEDX","LU0128526141.USD","LU0043850808.USD","LU0211977185.USD","LU1242518931.SGD","LU1188198961.HKD","LU0052750758.USD","LNGR","LU0823426308.USD","LU0181495838.USD","LU0326950275.SGD","LU0348735423.USD","BK1521","01672","KURE","BK1574","BK1589","06978","LU0561508036.HKD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196195031","title":"异动解读｜金斯瑞生物科技盘中下跌7.26%，AIDD概念板块整体回调承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1196195031","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196195031?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:31","pubTimestamp":1791855103,"startTime":"0","endTime":"0","summary":"10月13日，金斯瑞生物科技盘中下跌7.26%，报37.5港元，成交额1.11亿港元。消息面上，港股生物科技及AIDD概念板块延续回调压力，同行晶泰控股、英矽智能等同步走弱，市场情绪趋于谨慎。公司此前与英伟达及礼来TuneLab的合作虽被市场视为进入AI药物发现湿实验闭环的战略入口，但短期累积较大涨幅后，获利回吐与板块估值调整压力集中释放。金斯瑞生物科技股份有限公司主要从事生产及销售生命科学研究产品及服务，业务覆盖生命科学服务、生物制剂开发服务、工业合成生物产品、细胞疗法及经营管理等分部。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"金斯瑞生物科技下挫，AIDD板块集体承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674840307","title":"金斯瑞联手英伟达举办生命科学初创企业创投大赛","url":"https://stock-news.laohu8.com/highlight/detail?id=2674840307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674840307?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:51","pubTimestamp":1791769895,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4529","LU0942090050.USD","LU0726765562.USD","LU2065169927.USD","LU1732799900.SGD","BK4614","LU2242649171.HKD","LU1989772840.SGD","LU2237438978.USD","LU0056508442.USD","BK4548","LU1839511570.USD","LU2286300806.USD","LU0823421333.USD","LU0683600562.USD","LU0238689110.USD","LU0985320562.USD","LU2357125470.USD","BK4534","LU1699723380.USD","LU1674673691.USD","CLSE","LU1267930490.SGD","LU2237443549.SGD","NVDS.UK","SPTE","VT","LU0006306889.USD","LU0053666078.USD","LU0820562030.AUD","LU2236285917.USD","IE00BFSS7M15.SGD","LU0957808578.USD","LU1400636491.USD","LU2092937148.SGD","LU0787776722.HKD","SNVDAmain","LU0861579265.USD","LU0965509101.SGD","LU0096362180.USD","LU2403377893.USD","LU2750360641.GBP","LU0342679015.USD","IE00BMPRXR70.SGD","LU0820561818.USD","LU0868494708.USD","FDTX","LU1244550577.SGD","LU1718418525.SGD","BK4587","IE00BJJMRY28.SGD","LU2433249047.HKD","IE0003U64NQ7.SGD","DIPS","LU0157215616.USD","LU0234572021.USD","LU0107464264.USD","LU2417539215.USD","LU2746668461.USD","NVDG","SG9999014880.SGD","SGXZ23171101.USD","THMR","LU1366192091.USD","LU0289739343.SGD","LU0979878070.USD","IE000ITXATA3.USD","LU1674673428.USD","LU0158827948.USD","LU0345768153.USD","LU2087625088.SGD","IE00BJTD4V19.USD","LU2430703251.USD","LU0234570918.USD","LU0266013472.USD","LU1934455194.USD","LU2089985449.USD","IE00BWXC8680.SGD","HK0000819398.USD","LU0170899867.USD","LU1202635105.USD","IE00BSNM7G36.USD","SG9999014898.SGD","LU0820561909.HKD","LU1868837300.USD","LU0494093205.USD","IE00BKDWB100.SGD","IXN","09388","BK4549","BK4585","IE00B775SV38.USD","LU1145028129.USD","LU2125154778.USD","EFIV","LU1815333072.USD","LU2237443895.HKD","HK0000320223.HKD","LU1720051108.HKD","LU0390134368.USD","LU1979441026.SGD","LU2491050154.USD","NVD2.UK","SOXX","CNEQ","LU0265550359.USD","LU1791710400.SGD","SMH","LU2461242641.AUD","NVYY","LU1732800096.USD","09788","LU0795875086.SGD","LU1923622291.USD","LU0466842654.USD","LU2089284900.SGD","LU0210528500.USD","LU2756315318.SGD","LU0868494617.USD","LU2168564222.USD","LU2756315664.SGD","LU2413666426.HKD","SGXZ51526630.SGD","LU0210533765.USD","LU2065171402.SGD","IE00BKVL7J92.USD","LU2279689827.SGD","LU2506951792.HKD","LU0133085943.USD","LU2458330243.SGD","LU0081259029.USD","LU1645745479.HKD","LU1720051017.SGD","LU2294711713.HKD","LU0353189680.USD","LU2473716301.USD","LU1861559042.SGD","LU0310800379.SGD","LU1435385759.SGD","LU2077746001.SGD","LU2168564495.EUR","LU1934455277.USD","BK4608","LU2357305700.SGD","LU2023250330.USD","LU2065171311.SGD","SG9999018865.SGD","TYLG","LU2347655156.SGD","LU0553294199.USD","SGXZ44715902.SGD","HK0000914686.HKD","IE00BKPKM429.USD","LU2108987350.USD","LU0788109477.HKD","IE00BFSS8Q28.SGD","LU2322448791.USD","CHPX","07388","LU1989764748.USD","USXF","LU0143551892.USD","LU1935042991.SGD","LU2092627202.USD","LU0048584097.USD","LU1691799644.USD","LU2133065610.SGD","HK0000306701.USD","LU0964807845.USD","LU1037948897.HKD","LU1633808545.USD","LU0354030511.USD","LU0345770993.USD","LU0265550946.USD","SG9999015945.SGD","LU2458330169.SGD","LU1069347547.HKD","LU2237443978.SGD","LU0128525929.USD","IE0005OL40V9.USD","LU2237443622.USD","LU0256863902.USD","HK0000306685.HKD","LU0211328371.USD","LU0511384066.AUD","IE00BQXX3F31.USD","HK0000914660.USD","LU0738911758.USD","LU2543165471.USD","IE00BQXX3D17.EUR","LU2125909593.SGD","LU3102509885.SGD","LU1721428933.USD","LU2211815571.USD","LU0289960550.SGD","SMHX","IE00B3M56506.USD","IE00BK4W5L77.USD","LU0124676726.USD","LU1992135399.USD","IE00BJTD4N35.SGD","LU2552382132.HKD","LU0345769128.USD","LU2023250504.SGD","LU0109392836.USD","LU0965509283.SGD","IE00BHPRN162.USD","LU2244417387.USD","NVDD","TEK","TTXU","ANV","IE00BK4W5M84.HKD","LU2125154935.USD","LU1242518857.USD","LU2463028550.USD","GB00BDT5M118.USD","LU0323239441.USD","LU1244550221.USD","IE0004086264.USD","IE0001KFT4U8.USD","NVDX","AGOX","LU1791710582.SGD","LU2100268510.USD","LU2265009873.SGD","SG9999000418.SGD","LU1400636574.HKD","NVIW.SI","LU1144417596.USD","LU0079474960.USD","LU0689472784.USD","LU0308772762.SGD","IE000Q6AESB8.SGD","LU0395794307.EUR","IE00B3S45H60.SGD","NVII","LU0689626769.HKD","LU2083900584.USD","BK4503","LU1037948541.HKD","LU0528227936.USD","LU0898699433.AUD","LU1951200564.SGD","USD","BK4598","LU0256863811.USD","2NVD.UK","LU1244550494.USD","LU1496350502.SGD","LU0096364046.USD","LU0316494557.USD","LU0661504455.SGD","LU1316542783.SGD","LU1429558221.USD","LU0070217475.USD","BK4551","BK4527","LU0345769631.USD","LU1880398471.USD","LU0320765059.SGD","IE000KEQY171.SGD","BK4605","LU2028103732.USD","CMAG","LU0882574139.USD","LU0354030438.USD","LU2264538146.SGD","LU0082616367.USD","IE0004445015.USD","LU0323591593.USD","LU1571399168.USD","LU0069063385.USD","BK1583","LU0345770308.USD","SGXZ80539844.SGD","LU2361044949.HKD","LU2360032135.SGD","LU0158827781.USD","LU0672654240.SGD","LU1551013342.USD","LU2249611893.SGD","LU0965508806.USD","IE00B19Z8W00.USD","LU2954938101.SGD","LU1852331112.SGD","LU1323610961.USD","LU0274383776.USD","LU2552382058.USD","LU1084165304.USD","BK4588","LU1803068623.USD","SG9999015358.SGD","BK4612","LU2213496289.HKD","SG9999014567.USD","LU2125909916.SGD","LU2394011477.USD","LU0097036916.USD","HK0000304805.HKD","IE00B5TLWC47.USD","FAI","LU1935042488.USD","LU0444973449.USD","LU0203202063.USD","SGXZ31699556.SGD","LU2271345857.HKD","LU1035775433.USD","IE00B19Z8X17.USD","LU0225283273.USD","ESUM","LU2023251221.USD","LU2087621335.USD","LU1066051225.USD","IE000YTNTUN2.SGD","FTEC","IE00BDCRKT87.USD","LU2896262040.SGD","LU0472753341.HKD","LU0077335932.USD","NVDY","BK1141","ARTY","LU0545039389.USD","LU1116320737.USD","LU1642822529.SGD","LU2125909759.SGD","LU0724617625.USD","LU1868837136.USD","LU0823414551.USD","LU2750360997.AUD","LU2361045086.USD","IE00BJLML261.HKD","LU0106261372.USD","LU0276348264.USD","LU1868836914.USD","01548","LU0949170772.SGD","LU1232071149.USD","SG9999014559.SGD","LU2491049909.HKD","AIFD","IE0004445239.USD","LU2247934214.USD","LU0203201768.USD","LU2456880835.USD","LU1983260115.SGD","SG9999015986.USD","SGXZ99366536.SGD","NVDW","LU1880398554.USD","LU0444971666.USD","LU2148611432.USD","LU2168564149.EUR","LU2430703095.HKD","LU0348723411.USD","LU0061474960.USD","IE00BMPRXN33.USD","LU2125909247.SGD","LU0708995401.HKD","LU1935043023.USD","LU1267930573.SGD","IE0034235303.USD","LU1814569148.SGD","BK4579","LU2191332357.HKD","BK4543","LU2462591277.SGD","LU1629891620.HKD","IETC","LU0823434583.USD","SNVD.UK","BK4581","ABFL","LU2065170008.USD","IE000W1ABFV2.USD","LU0011850046.USD","LU0912757837.SGD","LU1988902786.USD","LU2592432038.USD","LU2505996509.AUD","LU1127390331.HKD","NULC","IE00BZ199S13.USD","LU2746668974.SGD","LU2471134523.USD","LU1935043452.HKD","LU1923623000.USD","SGXZ81514606.USD","BK4567","LU2491050071.SGD","NVDB","LU1989772923.USD","LU0057025933.USD","LU1003077747.HKD","LU2237443465.HKD","LU0786609619.USD","LU2097344357.USD","IE00BN29S564.USD","LU2063271972.USD","NVDU","LU2637965513.SGD","LU1934455863.HKD","07788","LU1551013425.SGD","LU1670756490.USD","LFGY","ESLG","LU2250418816.HKD","BK4532","IE00B19Z9505.USD","WISE","LU0310799852.SGD","LU0823421416.USD","LU2347655073.USD","LU0823414478.USD","IE00BMPRXQ63.HKD","LU1778281490.HKD","LU2462591350.SGD","JGRO","LU0211327993.USD","TTEQ","LU1066051498.USD","LU1935042215.USD","LU1803068979.SGD","HK0000320264.USD","GAMR","LU2237443382.USD","LU1917777945.USD","SG9999014542.SGD","LU0345768740.USD","LU0557290698.USD","LU2505996681.GBP","SG9999018857.SGD","LU1623119135.USD","LU1914381329.SGD","LU2471134952.CNY","LU0138981039.USD","LU0061475181.USD","LU2360106780.USD","SG9999002224.SGD","LU2047632596.USD","BK4592","LU1804176565.USD","IE00B7KXQ091.USD","LU1821325948.USD","NVDA","LU0210536198.USD","LU0719512351.SGD","LU2272731600.USD","SG9999014914.USD","BK4550","BK4533","LU0080751232.USD","HK0000532082.HKD","BK4141","VGT","SG9999014575.USD","LU1366333091.USD","LU2272731865.HKD","NVDS","IE00B3SWFQ91.USD","LU2487616109.SGD","LU0215105999.USD","LU0109391861.USD","ROM","NVD3.UK","IE00B4YYXB79.USD","LU2168564065.EUR","CHAT","LU1548497426.USD","SG9999015952.SGD","LU1119994496.HKD","LU0708994859.HKD","LU0127658192.USD","LU1242518931.SGD","LU1267930730.SGD","LU0889565833.HKD","LU2322448957.HKD","LU2430703178.SGD","NVDO","LU2237957902.USD","LU1712237335.SGD","LU2452424414.USD","LU0198837287.USD","LU1935043536.SGD","LU0957791311.USD","IE0004091025.USD","LU2106854487.HKD","LU0187121727.USD","LU1280957306.USD","IE0009G5SDU7.USD","METV","LU1116320901.HKD","SG9999017495.SGD","NVD","3NVD.UK","SG9999015978.USD","LU0823434740.USD","LU0154236417.USD","SHOC","LU2999663052.SGD","LU0061474705.USD","LU0251132253.USD","LU1153585028.USD","SOXY","LU2326559502.SGD","LU0174119429.USD","IE00BDRTCR15.USD","SG9999014906.USD","IE00B1BXHZ80.USD","IE0034235295.USD","LU0943347566.SGD","LU1861220033.SGD","LU1868836591.USD","LU0417517546.SGD","LU0267386448.USD","LU2089283258.USD","LU2237957811.SGD","SG9999004303.SGD","LU0795875169.SGD","IE00B5949003.HKD","LU2242650005.HKD","LU1400636657.SGD","SG9999001424.SGD","LU1261432733.SGD","BK4554","HK0000304797.USD","LU1861127337.USD","LU1923622614.USD","LU2471134796.USD","NVDL","LU1861558580.USD","LU0353189763.USD","NVC","LU1035773651.USD","LU1069344957.HKD","LU2420271590.USD","LU2054465674.USD","LU1066051811.HKD","IE00B775H168.HKD","LU2361044865.SGD","LU2381873111.SGD","LU2462157665.USD","AIPI","LU1496350171.SGD","IE00BJJMRX11.SGD","IE00BQXX3C00.GBP","LU2168563687.JPY","LU0642271901.SGD","LU1989764664.SGD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0094547139.USD","LU2552382215.SGD","SG9999002232.USD","LU2413666699.HKD","LU2290526834.HKD","SOXQ","ILDR","LU0289961442.SGD","IE00B1XK9C88.USD","LU0476273544.USD","SNPE","SG9999015341.SGD","LU1861215975.USD","LU0072462426.USD","LU1868836757.USD","LU1974910355.USD","LU1066053197.SGD","LU2860962120.EUR","BK1576","LU2602419157.SGD","LU2360107168.USD","LU0323240290.USD","LU1064131342.USD","LU0347712357.USD","LU2272731782.SGD","LU1951198990.SGD","LU1992135472.HKD","TRFK","XLK","LU0175139822.USD","LU2097344431.USD","LU0029864427.USD","IE0034235188.USD","LU1815336760.USD","IE0009356076.USD","IE00BD6J9T35.USD","IE00BYXW3230.USD","IE00B4JS1V06.HKD","NVDQ","LU0965509010.AUD","LU2931357623.SGD","LU2471134879.HKD","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genscript.com","stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":-0.171},{"period":"3month","weight":1.133},{"period":"6month","weight":1.478},{"period":"1year","weight":1.1159},{"period":"ytd","weight":1.7633}],"compareEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0618},{"period":"6month","weight":-0.0895},{"period":"1year","weight":-0.0913},{"period":"ytd","weight":-0.0772}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"金斯瑞生物科技股份有限公司是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司。该公司通过五个分部开展业务。生命科学服务及产品分部提供全面的研究服务及产品。生物制剂开发服务分部以一个综合平台提供全面服务，旨在帮助生物制药及生物技术公司加快治疗性抗体及基因、细胞疗法产品的开发。工业合成生物产品分部通过使用基因工程建构非病源微生物株，提供工业酶开发和生产。细胞疗法分部发现和开发用于治疗液体及固体肿瘤的CAR-T疗法。经营管理分部主要为其他分部提供共享服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.000341},{"month":2,"riseRate":0.545455,"avgChangeRate":0.075475},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.060575},{"month":4,"riseRate":0.545455,"avgChangeRate":0.057883},{"month":5,"riseRate":0.454545,"avgChangeRate":0.061694},{"month":6,"riseRate":0.545455,"avgChangeRate":0.030877},{"month":7,"riseRate":0.636364,"avgChangeRate":0.112261},{"month":8,"riseRate":0.454545,"avgChangeRate":0.171691},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.035935},{"month":10,"riseRate":0.545455,"avgChangeRate":0.065839},{"month":11,"riseRate":0.6,"avgChangeRate":0.045101},{"month":12,"riseRate":0.3,"avgChangeRate":0.042047}],"exchange":"SEHK","name":"金斯瑞生物-一千","nameEN":"GENSCRIPT B-1K"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金斯瑞生物-一千(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金斯瑞生物-一千(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金斯瑞生物-一千,01548,金斯瑞生物-一千股票,金斯瑞生物-一千股票老虎,金斯瑞生物-一千股票老虎国际,金斯瑞生物-一千行情,金斯瑞生物-一千股票行情,金斯瑞生物-一千股价,金斯瑞生物-一千股市,金斯瑞生物-一千股票价格,金斯瑞生物-一千股票交易,金斯瑞生物-一千股票购买,金斯瑞生物-一千股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金斯瑞生物-一千(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金斯瑞生物-一千(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}